
ARBs, thiazides and DHP calcium blockers tied to fewer dementia markers than ACE drugs
An autopsy cohort found blood pressure drugs that stimulate angiotensin II signaling were linked to lower Alzheimer's biomarkers and less brain small-vessel disease than those that inhibit it.



